₹253.25 2.70 (1.08%)
03:40 PM, 23-Jan-2025₹254.40 1.95 (0.77%)
03:53 PM, 23-Jan-2025BSE : 524404
NSE : MARKSANS
Sector : Health care
ISIN Code : INE750C01026
Last Updated: 23-Jan-2025 | 03:40 PM IST
Market Cap (₹ Cr) | 11,477 |
Traded Value (₹ Cr) | 0.88 |
Volume (Shares) | 34,862 |
Face Value (₹) | 1 |
52-Week High (₹) | 358.50 |
52-Week High Date | 02-Dec-2024 |
52-Week Low (₹) | 126.05 |
52-Week Low Date | 14-Mar-2024 |
All Time High (₹) | 358.50 |
All Time High Date | 02-Dec-2024 |
All Time Low (₹) | 0.71 |
All Time Low Date | 06-Mar-2003 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 11,529 |
EPS - TTM (₹) [C] | 7.66 |
P/E Ratio (X) [C] | 33.21 |
Face Value (₹) | 1 |
Latest Dividend (%) | 60.00 |
Latest Dividend Date | 17-Sep-2024 |
Dividend Yield (%) | 0.24 |
Book Value Share (₹) [C] | 50.34 |
P/B Ratio (₹) [C] | 5.05 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Kotak Special Opportunities Fund - Direct (G) | 74.99 | 25,27,836 | 3.31 |
Kotak Special Opportunities Fund - Direct (IDCW) | 74.99 | 25,27,836 | 3.31 |
Kotak Special Opportunities Fund - Regular (G) | 74.99 | 25,27,836 | 3.31 |
Kotak Special Opportunities Fund - Regular (IDCW) | 74.99 | 25,27,836 | 3.31 |
UTI-Small Cap Fund - Direct (IDCW) | 66.01 | 22,25,075 | 1.40 |
UTI-Small Cap Fund - Direct (G) | 66.01 | 22,25,075 | 1.40 |
UTI-Small Cap Fund (IDCW) | 66.01 | 22,25,075 | 1.40 |
UTI-Small Cap Fund (G) | 66.01 | 22,25,075 | 1.40 |
Old Bridge Focused Equity Fund - Direct (IDCW) | 48.68 | 16,40,947 | 4.53 |
Old Bridge Focused Equity Fund - Direct (G) | 48.68 | 16,40,947 | 4.53 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 252.15 260.70 |
Week Low/High (₹) | 246.05 274.00 |
Month Low/High (₹) | 246.05 308.00 |
Year Low/High (₹) | 130.00 359.00 |
All time Low/High (₹) | 0.71 359.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -3.93% | -3.85% | -0.68 | -0.46% |
1 Month | -13.34% | -13.40% | -2.57 | -2.31% |
3 Month | -5.78% | -5.83% | -4.45 | -5.03% |
6 Month | 35.79% | 35.88% | -4.86 | -5.20% |
1 Year | 69.54% | 69.43% | 8.74 | 9.26% |
3 Year | 331.55% | 331.55% | 29.61 | 31.72% |
Chairman & Managing Director : Mark Saldanha
Company Sec. & Compli. Officer : Harshavardhan Panigrahi
Non-Exec. & Independent Dir. : Seetharama Raju Buddharaju
Whole-time Director : Sandra Saldanha
Non-Exec. & Independent Dir. : Digant Mahesh Parikh
Whole-time Director : Varddhman Vikramaditya Jain
Non-Exec. & Independent Dir. : Abhinna Sundar Mohanty
Non Executive Director : Sunny Sharma
Independent Director : Shailaja Vardhan
Registered Office: 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W),Mumbai,Maharashtra-400053 Ph: 91-22-40012000
1. What's the Marksans Pharma Ltd share price today?
Marksans Pharma Ltd share price was Rs 253.25 at 03:40 PM IST on 23rd Jan 2025. Marksans Pharma Ltd share price was up by 1.08% over the previous closing price of Rs 250.55. Marksans Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Marksans Pharma Ltd stock?
The performance of the Marksans Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Marksans Pharma Ltd?
Marksans Pharma Ltd has a market capitalisation of Rs 11,477 crore.
4. What is Marksans Pharma Ltd's 52-week high/low share price?
The Marksans Pharma Ltd’s 52-week high share price is Rs 358.50 and 52-week low share price is Rs 126.05.
5. Is the Marksans Pharma Ltd profitable?
On a consolidated basis, Marksans Pharma Ltd reported a profit of Rs 63.20 crore on a total income of Rs 339.99 crore for the quarter ended 2024. For the year ended Sep 2024, Marksans Pharma Ltd had posted a profit of Rs 97.76 crore on a total income of Rs 652.98 crore.
6. Which are Marksans Pharma Ltd’s peers in the Health care sector?
Marksans Pharma Ltd’s top 5 peers in the Health care sector are Sai Life, Alivus Life, Sanofi India, Marksans Pharma, Sanofi Consumer, Blue Jet Health, P & G Health Ltd.
7. Who owns how much in Marksans Pharma Ltd?
Key changes to the Marksans Pharma Ltd shareholding are as follows: